| Literature DB >> 10203718 |
J Tian1, A Olcott, L Hanssen, D Zekzer, D L Kaufman.
Abstract
Insights into tolerance and autoimmune processes have led to novel immunotherapeutics for inhibiting autoimmune disease in animal models. However, recent studies question the immune basis of some of these therapeutic strategies and raise concerns about their efficacy and safety. Here, we discuss the feasibility of extending the success of antigen-based immunotherapeutics for T-cell-mediated autoimmune diseases from animal models to humans.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10203718 DOI： 10.1016/s0167-5699(99)01445-0
Source DB: PubMed Journal: Immunol Today ISSN： 0167-5699